Repurposing antimalarial drug lumefantrine for glioblastoma
DISEASE CATEGORY: Cancer
INDICATION: Brain cancer
The antimalarial drug lumefantrine, an FLI1 inhibitor, could treat glioblastoma resistant to radiation and temozolomide. A cell-based screen of